Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AMN Healthcare Services, Inc. (NYSE: AMN) SEC filings page brings together the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents provide detailed information on AMN Healthcare’s financial condition, capital structure, governance and material events affecting its healthcare workforce solutions and staffing business.
Through periodic and current reports, investors can review how AMN Healthcare’s three reportable segments—Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions—contribute to its overall performance. Filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically include segment discussions, risk factors, management’s analysis and notes on non-GAAP measures like adjusted EBITDA and adjusted diluted EPS.
Current reports on Form 8-K highlight specific events, including earnings announcements, senior notes offerings, amendments to the company’s credit agreement, and changes to its by-laws. For example, AMN Healthcare has filed 8-Ks describing the issuance of senior notes due 2031, amendments to its secured revolving credit facility, and the adoption of amended and restated by-laws that align with developments in Delaware law and update stockholder meeting procedures.
On this page, users can also access filings related to capital markets activities and other material agreements, which explain the terms of AMN Healthcare’s debt instruments and covenants. These disclosures help investors understand the company’s leverage, maturity profiles and financial flexibility.
Stock Titan enhances access to these filings with AI-powered summaries that explain key points in plain language. Users can quickly see the main implications of lengthy documents, such as how a new notes offering affects the balance sheet or how governance changes may influence stockholder rights, while still having the option to review the full SEC filings.
AMN Healthcare Services (AMN) reported an insider transaction by its Chief Legal Officer. On 10/15/2025, 4,976 shares of common stock were acquired upon the vesting of Restricted Stock Units (transaction code M).
On the same date, 1,212 shares were withheld for taxes at $20.69 per share (code F). Following these transactions, the officer directly beneficially owned 20,496 shares. The RSUs were granted on 10/15/2024 under the AMN Healthcare 2017 Equity Plan and vest in two annual tranches.
AMN Healthcare Services (AMN) completed a refinancing move as its subsidiary issued $400.0 million 6.500% Senior Notes due January 15, 2031, guaranteed on a senior unsecured basis by the parent and certain subsidiaries. Interest is payable semi-annually on January 15 and July 15, commencing July 15, 2026. The notes are callable at 103.250% in 2027, 101.625% in 2028, and 100% thereafter; before October 15, 2027, up to 40% may be redeemed with equity proceeds at 106.500%, or otherwise at par plus a make‑whole premium. A change of control triggers a 101% repurchase offer.
The company also amended its revolving credit facility to $450.0 million (from $750.0 million) and extended maturity to October 6, 2030, while updating leverage covenants (max 5.25x through March 31, 2027; 5.00x through June 30, 2028; 4.75x thereafter) and adding a pricing tier at Net Leverage ≥4.25x. AMN expects to draw about $100.0 million on the revolver and, together with note proceeds and cash, redeem all $500.0 million 2027 notes on October 22, 2025.
AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes. The company also states that the issuer has delivered a Conditional Notice of Redemption for all $500 million aggregate principal amount of its outstanding senior unsecured notes due 2027, with redemption scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering.
AMN Healthcare Services, Inc. plans a Fifth Amendment to its Credit Agreement that extends the maturity of its secured revolving credit facility to October 2030 from February 2028 while reducing the facility size from $750.0 million to $450.0 million. The amendment also removes the ten basis point credit spread adjustment tied to the Adjusted Term SOFR Adjustment.
The Consolidated Net Leverage Ratio covenant will be revised to be no greater than 5.25 to 1.00. A new pricing tier for a Net Leverage Ratio of at least 4.25x sets margins of 2.00% for SOFR loans, 1.00% for Base Rate Loans, 2.00% for the Letter of Credit Fee and 0.35% for the Unused Fee. The administrative agent has indicated sufficient lender consents, with final documentation expected in the fourth quarter of 2025.
Whitney M. Laughlin, Chief Legal Officer of AMN Healthcare Services, reported on Form 4 that 483 restricted stock units (RSUs) vested on September 15, 2025, converting into 483 shares of AMN common stock. Of those shares, 118 were sold or withheld at $18.25 per share to satisfy tax withholding, leaving the reporting person with 16,732 shares beneficially owned after the transactions. The RSUs were originally granted under the AMN Healthcare 2017 Equity Plan on September 15, 2023 and vest in three annual tranches; the units have no expiration date. The report is a routine insider equity vesting and tax-withholding transaction rather than a discretionary open-market purchase or sale.
FMR LLC and its chair & CEO Abigail P. Johnson have filed a Schedule 13G disclosing a 6.2 % passive stake in AMN Healthcare Services, Inc. (AMN) as of 30 Jun 2025. The position equals 2,391,522.85 common shares.
- Sole voting power: 2,388,349 shares
- Sole dispositive power: 2,391,522.85 shares
- Shared voting/dispositive power: 0 shares
The filing is made under Rule 13d-1(b) by a parent holding company/control person. An affiliated fund, Fidelity Small Cap Value Fund, holds 1,980,849 shares (5.2 %) within the aggregate amount. The signatory certifies the stake is held in the ordinary course of business without intent to influence control.
While no purchase history or cost basis is provided, FMR’s >5 % ownership signals continued institutional interest in AMN. No other material events, financial results, or strategic actions are disclosed.